Sumitomo Pharma Co., Ltd.【JP:4506】Balance sheet

Market cap

¥1.16T

P/E ratio

12.6x

Summary Financials Dividends History Segments Ownership Workforce

Income statement Balance sheet Cash flow Other

	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2021/03	2022/03	2023/03	2024/03	2025/03
Cash and cash equivalents	-	30,553	54,922	71,408	79,201	137,296	101,708	193,698	202,984	143,478	29,047	23,116
Marketable securities, current	-	111,293	81,039	34,195	2,000	43,750	28,717	29,480	35,596	20,174	7,085	16,840
Accounts receivable, net	-	103,072	107,165	110,932	112,982	118,760	134,491	135,866	151,407	95,908	81,023	74,840
Inventories	-	50,749	48,100	54,973	34,190	66,889	79,368	92,215	99,021	94,405	115,350	94,222
Total current assets	-	401,699	421,584	376,454	271,187	373,268	364,090	459,795	499,521	381,860	269,569	253,168
Property, plant and equipment, net	-	65,160	61,824	59,253	46,837	59,485	65,748	64,966	64,091	58,909	57,895	46,648
Marketable securities, non-current	-	58,193	60,432	48,034	59,846	74,668	200,923	193,035	115,844	134,007	161,711	44,148
Total non-current assets	-	309,884	286,130	417,495	409,214	461,449	888,788	848,332	808,486	752,882	637,937	489,436
Total assets	-	711,583	707,715	793,950	809,684	834,717	1,252,878	1,308,127	1,308,007	1,134,742	907,506	742,604
Accounts payable	-	12,492	12,153	14,514	58,708	49,238	62,251	64,638	46,183	52,141	67,720	38,544
Short-term debt	-	-	1,010	40,000	3,500	8,673	272,960	23,341	25,085	90,588	285,517	46,440
Long-term debt, current	-	6,522	12,000	8,000	2,960	2,960	2,960	4,960	20,060	-	60,000	4,000
Total current liabilities	-	156,843	179,722	228,447	68,761	198,174	496,498	278,147	278,373	372,694	515,474	240,603
Long-term debt, non-current	-	20,000	8,000	-	119,367	108,367	66,326	285,263	260,434	255,997	146,105	274,800
Total non-current liabilities	-	103,718	81,520	104,846	50,531	138,405	124,275	381,802	356,065	355,266	235,896	332,522
Total liabilities	-	260,562	261,242	333,293	356,961	336,579	620,773	659,949	634,438	727,960	751,370	573,125
Common stock and paid-in capital	-	38,260	38,260	38,261	76,520	76,522	78,498	76,516	77,386	60,661	60,661	60,661
Retained earnings	-	326,686	341,401	363,627	494,447	431,799	457,330	508,677	514,210	280,999	-22,665	46,784
Stockholders' equity	398,540	451,021	446,472	460,656	561,109	498,138	632,105	648,178	673,569	406,782	156,136	169,479

Raw aggregated data